BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2957498)

  • 1. Photoaffinity labelling and solubilization on the central 5-HT1A receptor binding site.
    Gozlan H; Emerit MB; el Mestikawy S; Cossery JM; Marquet A; Besselievre R; Hamon M
    J Recept Res; 1987; 7(1-4):195-221. PubMed ID: 2957498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible blockade of central 5-HT1A receptor binding sites by the photoaffinity probe 8-methoxy-3'-NAP-amino-PAT.
    Emerit MB; Gozlan H; Marquet A; Hamon M
    Eur J Pharmacol; 1986 Aug; 127(1-2):67-81. PubMed ID: 2944752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the 5-HT1A receptor binding subunit in rat brain membranes using the photoaffinity probe [3H]8-methoxy-2-[N-n-propyl, N-3-(2-nitro-4-azidophenyl)aminopropyl]aminotetralin.
    Emerit MB; el Mestikawy S; Gozlan H; Cossery JM; Besselievre R; Marquet A; Hamon M
    J Neurochem; 1987 Aug; 49(2):373-80. PubMed ID: 3598578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins.
    Emerit MB; el Mestikawy S; Gozlan H; Rouot B; Hamon M
    Biochem Pharmacol; 1990 Jan; 39(1):7-18. PubMed ID: 2136995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
    Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHAPS solubilization of a G-protein sensitive 5-HT1A receptor from bovine hippocampus.
    Kline T; Park H; Meyerson LR
    Life Sci; 1989; 45(21):1997-2005. PubMed ID: 2532283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
    Emerit MB; Miquel MC; Gozlan H; Hamon M
    J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and biochemical characterization of rat hippocampal 5-hydroxytryptamine1A receptors solubilized by 3-[3-(cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS).
    el Mestikawy S; Cognard C; Gozlan H; Hamon M
    J Neurochem; 1988 Oct; 51(4):1031-40. PubMed ID: 2971097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoaffinity labeling of the 5-hydroxytryptamine 1A receptor in rat hippocampus.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Oct; 47(4):1066-72. PubMed ID: 3746296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatographic analyses of the serotonin 5-HT1A receptor solubilized from the rat hippocampus.
    el Mestikawy S; Taussig D; Gozlan H; Emerit MB; Ponchant M; Hamon M
    J Neurochem; 1989 Nov; 53(5):1555-66. PubMed ID: 2529352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.
    Hall MD; Gozlan H; Emerit MB; el Mestikawy S; Pichat L; Hamon M
    Neurochem Res; 1986 Jun; 11(6):891-912. PubMed ID: 3016581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible blockade of central 5-HT binding sites by 8-methoxy-2'-chloro-PAT.
    Emerit MB; Gozlan H; Hall MD; Hamon M; Marquet A
    Biochem Pharmacol; 1985 Mar; 34(6):883-92. PubMed ID: 3156602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
    Nénonéné EK; Radja F; Carli M; Grondin L; Reader TA
    J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel [(diazomethyl)carbonyl]-1,2,3,4-tetrahydronaphthalene derivatives as potential photoaffinity ligands for the 5-HT1A receptor.
    Kline TB; Nelson DL; Namboodiri K
    J Med Chem; 1990 Mar; 33(3):950-5. PubMed ID: 2137880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
    Hall MD; el Mestikawy S; Emerit MB; Pichat L; Hamon M; Gozlan H
    J Neurochem; 1985 Jun; 44(6):1685-96. PubMed ID: 3157780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum.
    Alexander BS; Wood MD
    J Pharm Pharmacol; 1988 Dec; 40(12):888-91. PubMed ID: 2907586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
    Gozlan H; Ponchant M; Daval G; Verge D; Menard F; Vanhove A; Beaucourt JP; Hamon M
    J Pharmacol Exp Ther; 1988 Feb; 244(2):751-9. PubMed ID: 2964524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective labelling of central 5-HT1A receptor binding sites by [3H]5-methoxy-3-(di-n-propylamino)chroman.
    Cossery JM; Gozlan H; Spampinato U; Perdicakis C; Guillaumet G; Pichat L; Hamon M
    Eur J Pharmacol; 1987 Aug; 140(2):143-55. PubMed ID: 2959487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.